Back
AppLovin Vs. Blueprint Medicines Industry Stock Comparison
Buy
95
APP
AppLovin
Last Price:
$510.00
Seasonality Move:
26.75%
Sell
24
BPMC
Blueprint Medicines
Last Price:
$93.91
Seasonality Move:
5.74%
Sell
24
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $93.94. The Score for BPMC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $93.94Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight selling pressure.
APP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 27.61 | Buy |
Relative Strength Index (14 RSI): | 81.06 | Buy |
Chaikin Money Flow: | 8396416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (325.61 - 409.41) | Buy |
Bollinger Bands (100): | (180.78 - 376) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.47 | Sell |
Relative Strength Index (14 RSI): | 34.2 | Sell |
Chaikin Money Flow: | -344768 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.13 - 114.53) | Sell |
Bollinger Bands (100): | (86.8 - 104.06) | Sell |
APP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 405.8 | Buy |
20-day SMA: | 378.27 | Buy |
50-day SMA: | 355 | Buy |
200-day SMA: | 181.11 | Buy |
8-day EMA: | 421.99 | Buy |
20-day EMA: | 387.54 | Buy |
50-day EMA: | 347.93 | Buy |
200-day EMA: | 217.84 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.9 | Sell |
20-day SMA: | 109.05 | Sell |
50-day SMA: | 99.72 | Sell |
200-day SMA: | 98.82 | Sell |
8-day EMA: | 101.64 | Sell |
20-day EMA: | 104.41 | Sell |
50-day EMA: | 101.45 | Sell |
200-day EMA: | 95.01 | Sell |
AppLovin Earnings Growth & APP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.46 per share, and an increase next year of $1.78 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $2.69 per share.
AppLovin Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |